News & Press Releases
Filter by:
Carveouts, Add-ons Key As PE Firms Strategize For 2024
December 19, 2023
Private Equity managers are facing challenges such as a downturn in private market valuations and difficulties in securing affordable debt for new deals. Private Equity Co-chair Matthew T. Simpson provided insights on the market to PitchBook, discussing strategies PE sponsors are expected to adopt in 2024 to optimize results.
TikTokers Put Consumers at Risk as Drug Ads Go Unchecked by FDA
December 14, 2023
Member Joanne Hawana was quoted in a Bloomberg Law article discussing how TikTokers put consumers at risk of misinformation as drug ads go unchecked by the FDA. Joanne comments on the Office of Prescription Drug Promotion’s efforts to conduct research projects to better comprehend how viewers understand information presented in direct-to-consumer advertising.
Exploring FDA's Stance on LDTs and AI
December 12, 2023
Of Counsel Benjamin Zegarelli appeared on MDDI’s Let’s Talk Medtech Podcast. Ben provides some important regulatory updates surrounding laboratory-developed tests, artificial intelligence, and software.
Got an Environmental Issue? Investors Are Scrutinizing Your Response
December 11, 2023
ESG Co-chair Jacob Hupart was quoted in an Agenda article discussing the increasing emphasis on proactive environmental risk management by corporate boards in response to costly regulatory settlements.
What US-Canada Critical Minerals Collab Means For Cos.
December 6, 2023
Senior VP of ML Strategies John Lushetsky, Private Equity Co-chair Matthew T. Simpson, Member Paul H. Dickerson, and Raj Gambhir co-authored an article in Law360 discussing the collaborative efforts between the US and Canada in the development of critical mineral and semiconductor supply chains.
Mintz Bolsters Healthcare Practice With Wiley Partner
December 5, 2023
Law360 detailed the arrival of Member Rachel Alexander to Mintz’s health law practice. Rachel represents clients in all aspects of managed care and payor regulatory, transactional, and litigation matters with a specialized focus on pharmacy benefit and drug pricing related issues.